TMC Life Sciences Berhad (TMCLIFE) Stock Overview
An investment holding company, provides healthcare services in Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
TMCLIFE Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
TMC Life Sciences Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.49 |
| 52 Week High | RM 0.57 |
| 52 Week Low | RM 0.38 |
| Beta | 0.40 |
| 1 Month Change | 1.03% |
| 3 Month Change | 5.38% |
| 1 Year Change | 18.07% |
| 3 Year Change | -14.04% |
| 5 Year Change | -32.88% |
| Change since IPO | -46.45% |
Recent News & Updates
Recent updates
TMC Life Sciences Berhad (KLSE:TMCLIFE) Could Be Struggling To Allocate Capital
May 02
TMC Life Sciences Berhad (KLSE:TMCLIFE) Seems To Use Debt Quite Sensibly
Feb 14We Think TMC Life Sciences Berhad (KLSE:TMCLIFE) Can Stay On Top Of Its Debt
Sep 29Investors Met With Slowing Returns on Capital At TMC Life Sciences Berhad (KLSE:TMCLIFE)
Aug 26Shareholder Returns
| TMCLIFE | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | 2.1% | 0.8% | 0.6% |
| 1Y | 18.1% | 25.8% | 12.3% |
Return vs Industry: TMCLIFE underperformed the MY Healthcare industry which returned 25.8% over the past year.
Return vs Market: TMCLIFE exceeded the MY Market which returned 12.3% over the past year.
Price Volatility
| TMCLIFE volatility | |
|---|---|
| TMCLIFE Average Weekly Movement | 5.6% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in MY Market | 11.6% |
| 10% least volatile stocks in MY Market | 2.7% |
Stable Share Price: TMCLIFE has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: TMCLIFE's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | n/a | Ahmad Bin Abdul Rahman | www.tmclife.com |
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; property investment; providing pharmacy services and products; management support services; development, marketing, and management of healthcare programmes; and research and development activities, as well as providing fertility consultancy, laboratory, and embryology services.
TMC Life Sciences Berhad Fundamentals Summary
| TMCLIFE fundamental statistics | |
|---|---|
| Market cap | RM 853.52m |
| Earnings (TTM) | RM 12.59m |
| Revenue (TTM) | RM 387.22m |
Is TMCLIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TMCLIFE income statement (TTM) | |
|---|---|
| Revenue | RM 387.22m |
| Cost of Revenue | RM 257.64m |
| Gross Profit | RM 129.57m |
| Other Expenses | RM 116.98m |
| Earnings | RM 12.59m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0072 |
| Gross Margin | 33.46% |
| Net Profit Margin | 3.25% |
| Debt/Equity Ratio | 19.1% |
How did TMCLIFE perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/14 18:00 |
| End of Day Share Price | 2026/04/14 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
TMC Life Sciences Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.